{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T02:09:36Z","timestamp":1717034976414},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T00:00:00Z","timestamp":1280966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11307-010-0391-0","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T15:23:02Z","timestamp":1280935382000},"page":"721-729","source":"Crossref","is-referenced-by-count":8,"title":["Biodistribution, Pharmacokinetics, and Nuclear Imaging Studies of 111In-labeled rGel\/BLyS Fusion Toxin in SCID Mice Bearing B Cell Lymphoma"],"prefix":"10.1007","volume":"13","author":[{"given":"Xiaoxia","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Ae","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,5]]},"reference":[{"key":"391_CR1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.192.7.953","volume":"192","author":"RKG Do","year":"2000","unstructured":"Do RKG, Hatada E, Lee H et al (2000) Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 192:953\u2013964","journal-title":"J Exp Med"},{"key":"391_CR2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","volume":"285","author":"PA Moore","year":"1999","unstructured":"Moore PA, Belvedere O, Orr A et al (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260\u2013263","journal-title":"Science"},{"key":"391_CR3","doi-asserted-by":"crossref","first-page":"15978","DOI":"10.1074\/jbc.274.23.15978","volume":"274","author":"A Mukhopadhyay","year":"1999","unstructured":"Mukhopadhyay A, Ni J, Zhai Y, Yu G-L, Aggarwal BB (1999) Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem 274:15978\u201315981","journal-title":"J Biol Chem"},{"key":"391_CR4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","volume":"189","author":"P Schneider","year":"1999","unstructured":"Schneider P, MacKay F, Steiner V et al (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189:1747\u20131756","journal-title":"J Exp Med"},{"key":"391_CR5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jlb.65.5.680","volume":"65","author":"HB Shu","year":"1999","unstructured":"Shu HB, Hu WH, Johnson H (1999) TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 65:680\u2013683","journal-title":"J Leukoc Biol"},{"key":"391_CR6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1515\/BC.1999.186","volume":"380","author":"C Tribouley","year":"2005","unstructured":"Tribouley C, Wallroth M, Chan V et al (2005) Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol Chem 380:1443\u20131447","journal-title":"Biol Chem"},{"key":"391_CR7","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1126\/science.1061965","volume":"293","author":"JS Thompson","year":"2001","unstructured":"Thompson JS, Bixler SA, Qian F et al (2001) BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293:2108\u20132111","journal-title":"Science"},{"key":"391_CR8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1126\/science.278.5335.138","volume":"278","author":"G-U Bulow von","year":"1997","unstructured":"von Bulow G-U, Bram RJ (1997) NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278:138\u2013141","journal-title":"Science"},{"key":"391_CR9","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1002\/j.1460-2075.1992.tb05482.x","volume":"11","author":"Y Laabi","year":"1992","unstructured":"Laabi Y, Gras MP, Carbonnel F et al (1992) A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. EMBO J 11:3897\u20133904","journal-title":"EMBO J"},{"key":"391_CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.192.1.129","volume":"192","author":"JS Thompson","year":"2000","unstructured":"Thompson JS, Schneider P, Kalled SL et al (2000) BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med 192:129\u2013136","journal-title":"J Exp Med"},{"key":"391_CR11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","volume":"404","author":"JA Gross","year":"2000","unstructured":"Gross JA, Johnston J, Mudri S et al (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995\u2013999","journal-title":"Nature"},{"key":"391_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-472X(01)00774-3","volume":"30","author":"B Javier","year":"2002","unstructured":"Javier B, John MT, David MH, Ronald L (2002) BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Exp Hematol 30:135\u2013141","journal-title":"Exp Hematol"},{"key":"391_CR13","doi-asserted-by":"crossref","first-page":"241a","DOI":"10.1182\/blood.V104.11.241.241","volume":"104","author":"BA MA","year":"2004","unstructured":"MA BA, Hewitt J et al (2004) Tumor targeting, dosimetry and clinical response data for lymphorad-131 (LR131; I-131 labeled B-lymphocyte stimulator) in patients with relapsed\/refractory non-Hodgkin's lymphoma. Blood 104:241a","journal-title":"Blood"},{"key":"391_CR14","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1016\/S0021-9258(18)43667-8","volume":"255","author":"F Stirpe","year":"1980","unstructured":"Stirpe F, Olsnes S, Pihl A (1980) Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A. J Biol Chem 255:6947\u20136953","journal-title":"J Biol Chem"},{"key":"391_CR15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj2770281","volume":"277","author":"S Sperti","year":"1991","unstructured":"Sperti S, Brigotti M, Zamboni M, Carnicelli D, Montanaro L (1991) Requirements for the inactivation of ribosomes by gelonin. Biochem J 277:281\u2013284","journal-title":"Biochem J"},{"key":"391_CR16","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1073\/pnas.122157899","volume":"99","author":"LM Veenendaal","year":"2002","unstructured":"Veenendaal LM, Jin H, Ran S et al (2002) In vitro and in vivo studies of a VEGF121\/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors. Proc Natl Acad Sci USA 99:7866\u20137871","journal-title":"Proc Natl Acad Sci USA"},{"key":"391_CR17","first-page":"585","volume":"32","author":"BM CD","year":"1994","unstructured":"CD BM, Sperti S, Montanaro L (1994) RNA present in post-ribosomal supernatants makes ribosomes susceptible to inactivation by gelonin and alpha-sarcin. Biochem Mol Biol Int 32:585\u2013596","journal-title":"Biochem Mol Biol Int"},{"key":"391_CR18","first-page":"3995","volume":"63","author":"MG Rosenblum","year":"2003","unstructured":"Rosenblum MG, Cheung LH, Liu Y, Marks JW III (2003) Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin. Cancer Res 63:3995\u20134002","journal-title":"Cancer Res"},{"key":"391_CR19","first-page":"865","volume":"5","author":"MG Rosenblum","year":"1999","unstructured":"Rosenblum MG, Shawver LK, Marks JW et al (1999) Recombinant immunotoxins directed against the c-erb-2\/HER2\/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models. Clin Cancer Res 5:865\u2013874","journal-title":"Clin Cancer Res"},{"key":"391_CR20","first-page":"6","volume":"3","author":"RMG MJ","year":"1991","unstructured":"MJ RMG, Cheung L, Rifkin R, Salmon S, Bartholomew R (1991) A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin. Mol Biother 3:6\u201313","journal-title":"Mol Biother"},{"key":"391_CR21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1083-8791(03)00129-0","volume":"9","author":"H Duzkale","year":"2003","unstructured":"Duzkale H, Pagliaro LC, Rosenblum MG et al (2003) Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195\/rGel. Biol Blood Marrow Transplant 9:364\u2013372","journal-title":"Biol Blood Marrow Transplant"},{"key":"391_CR22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1535-7163.MCT-06-0254","volume":"6","author":"M-A Lyu","year":"2007","unstructured":"Lyu M-A, Cheung LH, Hittelman WN et al (2007) The rGel\/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA. Mol Cancer Ther 6:460\u2013470","journal-title":"Mol Cancer Ther"},{"key":"391_CR23","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1182\/blood-2006-08-042424","volume":"109","author":"R Nimmanapalli","year":"2007","unstructured":"Nimmanapalli R, Lyu M-A, Du M et al (2007) The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells. Blood 109:2557\u20132564","journal-title":"Blood"},{"key":"391_CR24","first-page":"422","volume":"44","author":"TA Riccobene","year":"2003","unstructured":"Riccobene TA, Miceli RC, Lincoln C et al (2003) Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice. J Nucl Med 44:422\u2013433","journal-title":"J Nucl Med"},{"key":"391_CR25","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.2174\/1381612043383494","volume":"10","author":"PH Marathe","year":"2004","unstructured":"Marathe PH, Shyu WC, Humphreys WG (2004) The use of radiolabeled compounds for ADME studies in discovery and exploratory development. Curr Pharm Des 10:2991\u20133008","journal-title":"Curr Pharm Des"},{"key":"391_CR26","first-page":"1536","volume":"40","author":"G Pavlinkova","year":"1999","unstructured":"Pavlinkova G, Beresford GW, Booth BJM, Batra SK, Colcher D (1999) Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of mAb CC49 in colon carcinoma xenografts. J Nucl Med 40:1536\u20131546","journal-title":"J Nucl Med"},{"key":"391_CR27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nsb769","volume":"9","author":"DA Oren","year":"2002","unstructured":"Oren DA, Li Y, Volovik Y et al (2002) Structural basis of BLyS receptor recognition. Nature Struct Mol Biol 9:288\u2013292","journal-title":"Nature Struct Mol Biol"},{"key":"391_CR28","first-page":"445","volume":"48","author":"AR Hsu","year":"2007","unstructured":"Hsu AR, Cai W, Veeravagu A et al (2007) Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121\/rGel. J Nucl Med 48:445\u2013454","journal-title":"J Nucl Med"},{"key":"391_CR29","first-page":"2475","volume":"48","author":"DJ Buchsbaum","year":"1988","unstructured":"Buchsbaum DJ, Sinkule JA, Stites MS et al (1988) Localization and imaging with radioiodine-labeled monoclonal antibodies in a xenogeneic tumor model for human B-cell lymphoma. Cancer Res 48:2475\u20132482","journal-title":"Cancer Res"},{"key":"391_CR30","doi-asserted-by":"crossref","unstructured":"Lyu M-A, Rai D, Ahn KS et al. 2010. The rGel\/BLys fusion toxin inhibits diffuse large B cell lymphoma growth in vitro and in vivo. Neoplasia 12:366\u2013375","DOI":"10.1593\/neo.91960"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-010-0391-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-010-0391-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-010-0391-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T10:30:47Z","timestamp":1635935447000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-010-0391-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,5]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1007\/s11307-010-0391-0","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,5]]}}}